A U.S. study has found that less than half of psoriasis patients report frequently engaging in shared decision-making with their...

Guselkumab does not increase cancer risk in psoriasis patients compared to general and psoriasis populations.

Individuals with AD and asthma may be more likely to develop osteoarthritis.

Skin Spectrum Quarterly™: The Journal of Ethnodermatology is a new worldwide dermatology journal that focuses on the emerging...

New research has identified some factors that may lead to some skin cancers no longer responding to treatment. Published in Cancer...

Risankizumab has been shown to be efficacious and safe in patients with plaque psoriasis who have a suboptimal response to IL-17 inhibitors.

An anonymous, voluntary survey of 359 patients showed most considered having access to their medical records as a favourable development....

A group of researchers from Japan have developed a new model for the estimation of trans-epidermal water loss (TEWL) without the need for...